FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2168738650> ?p ?o ?g. }

• W2168738650 endingPage "691" @default.
• W2168738650 startingPage "686" @default.
• W2168738650 abstract "The proper dosage schedule of antibiotics has generally been determined empirically, due to the difficulty of clinical trials. Initially, the dosage was chosen to allow high sustained levels > MIC in the blood. Antibiotics (β lactams, tetracyclins, macrolides) were given at high doses three to six times daily, whatever their kinetic properties. The data obtained by Eagle with β lactams in animal models of streptococcal and treponemal infections outlined the importance of interval between doses on the in vivo efficacy. They also showed that increasing the dose of penicillin had a positive effect on the bactericidal activity only through the persistence of effective levels (>MIC) at the site of infection. Further illustrations were given through experimental and clinical studies with β lactams or other compounds on different types of infections: LRTIs, UTIs, meningitis, and endocarditis. The importance of both dynamic (i.e., pattern of bactericidal effect) and kinetic (elimination half-life) parameters was thus further identified. Information on toxicity with some compounds with a narrow therapeutic index, such as aminoglycosides, indicated that increasing the dose to enhance efficacy had some limitations. This led to numerous studies on the relations between concentration and toxicity, stating that nephro- or ototoxicity were not directly related to peak level in serum. Experimental studies showed that OD administration of aminoglycosides was both more efficient and less toxic than the multiple-dose regimen of the same daily amount. Economic considerations progressively justified attempts to both reduce the dose and the work load related to multiple administrations. Development of oral compounds able to be given as initial therapy or as a quick alternative to parenteral administration raised the question of applicability to oral route of OD dosing. High bioavailability is required to ensure efficacy. Oral OD dosing may be discussed in more or less severe infectious processes and in some difficult-to-cure chronic infections." @default.
• W2168738650 created "2016-06-24" @default.
• W2168738650 creator A5034661620 @default.
• W2168738650 date "1992-08-01" @default.
• W2168738650 modified "2023-09-26" @default.
• W2168738650 title "Single-Dose Antibiotic Therapy: What Has the Past Taught Us?" @default.
• W2168738650 cites W1678057383 @default.
• W2168738650 cites W1965725897 @default.
• W2168738650 cites W1972773258 @default.
• W2168738650 cites W1983474709 @default.
• W2168738650 cites W1994457186 @default.
• W2168738650 cites W1994825893 @default.
• W2168738650 cites W2004705457 @default.
• W2168738650 cites W2010623987 @default.
• W2168738650 cites W2020328556 @default.
• W2168738650 cites W2026059809 @default.
• W2168738650 cites W2031767177 @default.
• W2168738650 cites W2047460083 @default.
• W2168738650 cites W2048047136 @default.
• W2168738650 cites W2048101866 @default.
• W2168738650 cites W2059275495 @default.
• W2168738650 cites W2065850189 @default.
• W2168738650 cites W2067868662 @default.
• W2168738650 cites W2069662153 @default.
• W2168738650 cites W2072291253 @default.
• W2168738650 cites W2077365277 @default.
• W2168738650 cites W2079889984 @default.
• W2168738650 cites W2089436507 @default.
• W2168738650 cites W2092588429 @default.
• W2168738650 cites W2095043796 @default.
• W2168738650 cites W2102765259 @default.
• W2168738650 cites W2114422486 @default.
• W2168738650 cites W2121585320 @default.
• W2168738650 cites W2132869689 @default.
• W2168738650 cites W2165414057 @default.
• W2168738650 cites W2317034014 @default.
• W2168738650 cites W2319326630 @default.
• W2168738650 cites W2322335363 @default.
• W2168738650 cites W2328863826 @default.
• W2168738650 cites W4317523487 @default.
• W2168738650 doi "https://doi.org/10.1002/j.1552-4604.1992.tb03870.x" @default.
• W2168738650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1487556" @default.
• W2168738650 hasPublicationYear "1992" @default.
• W2168738650 type Work @default.
• W2168738650 sameAs 2168738650 @default.
• W2168738650 citedByCount "11" @default.
• W2168738650 countsByYear W21687386502021 @default.
• W2168738650 crossrefType "journal-article" @default.
• W2168738650 hasAuthorship W2168738650A5034661620 @default.
• W2168738650 hasConcept C112705442 @default.
• W2168738650 hasConcept C126322002 @default.
• W2168738650 hasConcept C150903083 @default.
• W2168738650 hasConcept C162156334 @default.
• W2168738650 hasConcept C174802600 @default.
• W2168738650 hasConcept C177713679 @default.
• W2168738650 hasConcept C19831878 @default.
• W2168738650 hasConcept C207001950 @default.
• W2168738650 hasConcept C2776694085 @default.
• W2168738650 hasConcept C2778239845 @default.
• W2168738650 hasConcept C2778534666 @default.
• W2168738650 hasConcept C2780035454 @default.
• W2168738650 hasConcept C2781413609 @default.
• W2168738650 hasConcept C29730261 @default.
• W2168738650 hasConcept C501593827 @default.
• W2168738650 hasConcept C71924100 @default.
• W2168738650 hasConcept C86803240 @default.
• W2168738650 hasConcept C89423630 @default.
• W2168738650 hasConcept C98274493 @default.
• W2168738650 hasConceptScore W2168738650C112705442 @default.
• W2168738650 hasConceptScore W2168738650C126322002 @default.
• W2168738650 hasConceptScore W2168738650C150903083 @default.
• W2168738650 hasConceptScore W2168738650C162156334 @default.
• W2168738650 hasConceptScore W2168738650C174802600 @default.
• W2168738650 hasConceptScore W2168738650C177713679 @default.
• W2168738650 hasConceptScore W2168738650C19831878 @default.
• W2168738650 hasConceptScore W2168738650C207001950 @default.
• W2168738650 hasConceptScore W2168738650C2776694085 @default.
• W2168738650 hasConceptScore W2168738650C2778239845 @default.
• W2168738650 hasConceptScore W2168738650C2778534666 @default.
• W2168738650 hasConceptScore W2168738650C2780035454 @default.
• W2168738650 hasConceptScore W2168738650C2781413609 @default.
• W2168738650 hasConceptScore W2168738650C29730261 @default.
• W2168738650 hasConceptScore W2168738650C501593827 @default.
• W2168738650 hasConceptScore W2168738650C71924100 @default.
• W2168738650 hasConceptScore W2168738650C86803240 @default.
• W2168738650 hasConceptScore W2168738650C89423630 @default.
• W2168738650 hasConceptScore W2168738650C98274493 @default.
• W2168738650 hasIssue "8" @default.
• W2168738650 hasLocation W21687386501 @default.
• W2168738650 hasLocation W21687386502 @default.
• W2168738650 hasOpenAccess W2168738650 @default.
• W2168738650 hasPrimaryLocation W21687386501 @default.
• W2168738650 hasRelatedWork W1906640546 @default.
• W2168738650 hasRelatedWork W1989807674 @default.
• W2168738650 hasRelatedWork W2004556784 @default.
• W2168738650 hasRelatedWork W2154439517 @default.
• W2168738650 hasRelatedWork W2323576217 @default.
• W2168738650 hasRelatedWork W2378945660 @default.

• next